Quantum Genomics to Present at Rodman & Renshaw 18th Annual Conference in New York on September 13
September 06, 2016 08:00 ET | Quantum Genomics
CEO Lionel Ségard to discuss clinical updates and latest company developments PARIS and NEW YORK, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a...
Quantum Genomics granted two new U.S. patents covering lead product QGC001
May 17, 2016 12:00 ET | Quantum Genomics
PARIS & NEW YORK, May 17, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company developing new therapies for unmet medical needs in the...
Quantum Genomics Raises €8.6 Million in U.S. and Europe
March 24, 2016 08:00 ET | Quantum Genomics
PARIS and NEW YORK, March 24, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a biopharmaceutical company focused on the development of new therapies for unmet...
Quantum Genomics Expands U.S. Presence to Advance Its Development Programs for Cardiovascular Diseases
February 03, 2016 14:20 ET | Quantum Genomics
Establishes U.S. Clinical Advisory BoardAnnounces Plans to Open U.S. Office PARIS, France, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Quantum Genomics (Alternext - FR0011648971 - ALQGC), a...